Leucine and Omega-3 Combination for Hypercalcemia Symptom Relief
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for hypercalcemia fail to effectively reduce nausea, vomiting, and other associated symptoms, and do not adequately manage abnormal blood plasma calcium levels, which can lead to severe health issues such as coma or cardiac arrest.
Innovation Solution
A combination of a leucine source and an ω-3 polyunsaturated fatty acid source, specifically administered as part of a nutritional, pharmaceutical, or nutraceutical composition, is used to reduce nausea and vomiting urges, regulate blood plasma calcium homeostasis, and maintain or normalize calcium levels, thereby alleviating symptoms like fatigue and muscle function impairment.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-affected harmful factors
If conventional treatments are used for hypercalcemia, then calcium levels can be managed to some extent, but nausea and vomiting symptoms are not effectively reduced
Solution Approach 1:
The patent combines leucine supplementation with omega-3 polyunsaturated fatty acid supplementation to create a synergistic treatment approach. This combination addresses both the calcium regulation aspect and the symptom management aspect (nausea and vomiting) that were not effectively treated by conventional single-agent therapies, thereby resolving the contradiction between symptom relief and treatment effectiveness.
Solution Approach 2:
The invention uses a composite nutritional intervention comprising multiple components (leucine, omega-3 fatty acids, and their interaction with calcium metabolism). This composite approach provides comprehensive treatment that simultaneously manages calcium levels and alleviates associated symptoms, improving overall treatment reliability while addressing harmful symptoms.
2Reliability
If calcium levels are regulated to prevent severe hypercalcemia, then serious health issues can be avoided, but existing treatments do not adequately manage abnormal blood plasma calcium levels
Solution Approach 1:
The patent employs a feedback mechanism where leucine and omega-3 fatty acids work together to regulate calcium homeostasis. The combination provides adequate calcium level management that prevents severe hypercalcemia and its associated harmful effects, improving both reliability of calcium control and prevention of serious health issues.
Solution Approach 2:
The invention changes the physiological parameters of calcium metabolism by introducing leucine and omega-3 fatty acids that modify calcium absorption, excretion, and homeostasis regulation. This parameter change enables adequate management of abnormal blood plasma calcium levels while preventing severe health complications.
3Object-affected harmful factors
If leucine and omega-3 polyunsaturated fatty acid are combined, then nausea and vomiting are reduced and calcium homeostasis is regulated, but the formulation complexity increases
Solution Approach 1:
The patent creates a multi-functional formulation where leucine and omega-3 fatty acids serve multiple purposes: regulating calcium homeostasis, reducing nausea and vomiting, and providing nutritional support. This multi-functionality justifies the formulation complexity by delivering comprehensive treatment benefits through a single combined intervention.
Data Source
Figure 1A~1B
Figure 2
Figure 3
AI summary
The present invention relates to a combination of a leucine source and at least one unsaturated fatty acid source for prophylactic or therapeutic treatment of hypercalcaemia. The invention further relates to a combination of a leucine source and at least one unsaturated fatty acid source for reducing or avoiding a reduction in bone mineral density in a subject or for in vivo regulating of the blood plasma calcium homeostasis.